Immunotherapy Trials

Immunotherapy Trials is a type of clinical trial within neuro-oncology that investigates the efficacy and safety of immunotherapeutic interventions—such as immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies—in harnessing or modulating the patient’s immune system to target and eliminate malignant central nervous system tumors.

1.3K

Publications

107.8K

Citations

10.3K

Authors

2.3K

Institutions

Publications per year

2017–2026

646

Authors

10.3K

  1. DA
    David A. Reardon

    Dana-Farber Cancer Institute, United States

    29 publications · 5.2K citations

    21

    h-index

  2. PM
    Paul M. Sondel

    University of Wisconsin–Madison, United States

    28 publications · 2.2K citations

    20

    h-index

  3. NV
    Nai‐Kong V. Cheung

    Memorial Sloan Kettering Cancer Center, United States

    20 publications · 1.3K citations

    19

    h-index

  4. JA
    Jacquelyn A. Hank

    University of Wisconsin–Madison, United States

    21 publications · 2K citations

    18

    h-index

  5. BH
    Brian H. Kushner

    Memorial Sloan Kettering Cancer Center, United States

    17 publications · 1.1K citations

    17

    h-index

1–5 of 10.3K

Venues

  1. Journal of Clinical Oncology

    175 publications · 13.8K citations

    51

    h-index

  2. Clinical Cancer Research

    52 publications · 6.4K citations

    41

    h-index

  3. Journal for ImmunoTherapy of Cancer

    JITC · 49 publications · 3.9K citations

    31

    h-index

  4. PubMed

    Repository · 79 publications · 3.6K citations

    31

    h-index

  5. Cancer Immunology Immunotherapy

    37 publications · 2.3K citations

    24

    h-index

1–5